NVS vs REGN
Novartis AG Common Stock · Regeneron Pharmaceuticals, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | NVS | REGN |
|---|---|---|
| Price | $141.28 | $803.90 |
| Market Cap | $269.58B | $75.90B |
| P/E | 19.28 | 16.85 |
| P/B | 5.84 | 2.39 |
| P/S | — | 5.29 |
| ROE | 30.3% | 14.2% |
| Net Margin | — | 31.4% |
| Gross Margin | — | — |
| Revenue Growth | — | 1.0% |
| Dividend Yield | — | — |
| EPS | $7.33 | $47.72 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.